Airway Therapeutics Opens International Clinical Trial Sites and Treats First Patient in Spain in Phase 1b Study of Zelpultide Alfa (AT-100) in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD)

Further plans for expansion in Europe include up to ten clinical trial sites across Spain by end of Q32022 and up to three sites in Italy by end of

Related Keywords

Spain ,Italy ,United States ,Valencia ,Carabobo ,Venezuela ,Marc Salzberg ,Division Of Neonatology ,Airway Therapeutics ,World Health Organization ,Airway Therapeutics Inc ,Prnewswire Airway Therapeutics Inc ,Airway Europe ,Clinical Trial Site Leader At Spain University ,European Medicines Agency ,United States Adopted Names ,Clinical Trial Site Leader ,Orphan Drug ,